Top Markets
#1 Helium Helium +106.09%
#2 MowCat MowCat +86.97%
#3 Seeker Seeker +55.97%
#4 UnifAI Network UnifAI Network +35.21%
#5 TENDIES TENDIES +28.13%
#6 Zylo Ecosystem Zylo Ecosystem +22.49%
#7 Tensor Tensor +20.12%
#8 Pons Pons +19.98%
#9 pipedog pipedog +19.61%
#10 MarsCoin MarsCoin +16.29%
Coin of the day
Helium Helium
Settings
Language
ENGLISH
Currency
USD
Theme
Zhejiang AngLiKang Pharmaceutical CO.,LTD. Zhejiang AngLiKang Pharmaceutical CO.,LTD.

Zhejiang AngLiKang Pharmaceutical CO.,LTD.

002940
Rank in Stocks #11260
Zhejiang AngLiKang Pharmaceutical CO.,LTD. is a company primarily focused on... Zhejiang AngLiKang Pharmaceutical CO.,LTD. is a company primarily focused on the manufacturing and distribution of various pharmaceutical goods. Their operations span the production and sale of active pharmaceutical ingredients (APIs), finished drug formulations, and empty capsules for medical use. The company's existing product line encompasses treatments for a variety of conditions, including anti-infective agents, antihypertensives for blood pressure management, medications for digestive system health, and respiratory preparations. Beyond its current offerings, AngLiKang is also deeply involved in drug research and development. Their R&D efforts are concentrated on creating new therapies, with a particular emphasis on oral cephalosporin antibiotics, as well as treatments for cardiovascular, renal (kidney), and central nervous system diseases. The company was established in 2001 and maintains its headquarters in Shengzhou, China.
Share Price
$3.69
Last synced: 2026-08-28
Market Cap
$722.97M
Change (1 day)
-1.62%
Change (1 year)
-46.81%
Country
CN
Trade Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940)

Category

Healthcare
Revenue for Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940)
Revenue in Aug 2026 TTM: 0
According to Zhejiang AngLiKang Pharmaceutical CO.,LTD. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Zhejiang AngLiKang Pharmaceutical CO.,LTD. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN